M-Plant is the first GMP (Good Manufacturing Practice) facility of Medinno Inc. It was completed in June 2020. M-Plant provides excellent high-tech biopharmaceuticals by securing safety and quality from high-tech biopharmaceutical sources to product shipments.
GMP Management
Qualification with IOPQ and
environmental monitoring for aseptic
manufacturing process
GMP Accreditation
GMP for high-quality medical
products complied with new MFDS
regulations related to human stem cells
GMP Size & Location
M-Plant (735.8㎡) located in
Geumcheon-gu, Seoul, is a
brand-new facility invested by
7 billion won
Manufacturing Area Quality Control Area Storage Area Utility Area
Personnel with GMP specialty Procedures and Processes that are defined, documented, and recorded Premises that are validated and calibrated Products that have specifications from raw materials to end products
Quality Management System Quality Assurance System Quality Control System Validation Management System Risk Management System
Biosafety Cabinet (in Class B)
CO2 Incubator (in Class B)
Biochemical Laboratory
Clean Area (Class C)
Storage Warehouse
HVAC System